Min Yang
Vice President
Boston
Education
Ph.D. and M.S., health outcomes and pharmacy practice, University of Texas at Austin; M.D., clinical medicine, Suzhou Medical College
Summary of Experience
Dr. Yang specializes in health economics and outcomes research. She works closely with pharmaceutical and device companies to support product launch, product positioning, and post-market research by designing and analyzing clinical trial data, insurance claims databases, electronic medical charts, and primary survey data. Her expertise also includes building predictive models for health risks, and developing software to support medical decision making. Collaborating frequently with academic experts and clinical key opinion leaders, Dr. Yang has extensive experience in patient-reported outcomes (e.g., health-related quality of life, patient preference in medical product features) and clinician-reported outcomes, and has worked on development and validation of a number of such instruments in various disease areas. Dr. Yang's research has been published in many peer-reviewed journals and presented at many clinical and economic research conferences. She is a licensed oncology surgeon in China. Prior to joining Analysis Group, Dr. Yang was a senior scientist at QualityMetric (now part of Optum, Inc.).
Selected Publishing
-
Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials
Value in Health. Jan 2018;21(1):1-8
2018Papp KA, Yang M, Sundaram M, Jarvis J, Betts KA, Bao Y, Signorovitch JE
-
Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States
Health and Quality of Life Outcomes, September 21, 2018
2018 -
Health-related quality of life and work productivity associated with HiSCR and NRS30 response among patients with moderate to severe hidradenitis suppurativa
Journal of the American Academy of Dermatology, June 2017, Volume 76, Issue 6
2017 -
Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk
American Journal of Epidemiology. 2017;186(6):736-744
2017Aroner SA, Yang M, Li J, Furtado JD, Sacks FM, Tjønneland A, Overvad K, Cai T, Jensen MK.
-
Effectiveness and healthcare costs among stabilised rheumatoid arthritis patients with dose reduction of adalimumab or etanercept in real world
Clinical and Experimental Rheumatology. Sep-Oct 2017;35(5):791-798
2017Yang M, Galebach PJ, Signorovitch JE, Garg V
-
Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US
J Med Econ. 2015 Mar 27:1-10
2015Cohen R, Skup M, Ozbay AB, Rizzo J, Yang M, Diener M, Chao J.
-
Assessment of time to clinical response, a proxy for discharge readiness, among hospitalized patients with community-acquired pneumonia who received either ceftaroline fosamil or ceftriaxone in two ph
Antimicrob Agents Chemother. 2015 Feb; 59(2):1119-26
2015Lodise TP, Anzueto AR, Weber DJ, Shorr AF, Yang M, Smith A, Zhao Q, Huang X, File TM
-
Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing’s disease
Eur J Endocrinol. 2014 Jul; 171(1):89-98
2014Webb SM, Ware JE, Forsythe A, Yang M, Badia X, Nelson LM, Signorovitch JE, McLeod L, Maldonado M, Zgliczynski W, de Block C, Portocarrero-Ortiz L, Gadelha M
-
Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment
Br J Dermatol. 2014 Dec; 171(6):1434-42
2014Kimball AB, Jemec GB, Yang M, Kageleiry A, Signorovitch JE, Okun MM, Gu Y, Wang K, Mulani P, Sundaram M
-
A health-related quality-of-life study comparing Vitala continence control device versus traditional pouch system only in patients with end colostomy
Eur J Gastroenterol Hepatol. 2013 Jun; 25(6):739-47
2013Hoch J, Yang M, Yan S, van den Broek N, Xie J, Warusavitarne J.
-
Pain relief and tolerability balance of immediate release tapentadol or oxycodone treatment for patients with moderate to severe osteoarthritis or low back pain
Pain Med. 2012 Sep; 13(9):1110-20
2012Kavanagh S, Kwong WJ, Hammond GC, Nelson W, Upmalis D, Yang M
-
Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine
Headache. 2012 Mar; 52(3):409-21
2012Bagley CL, Rendas-Baum R, Maglinte GA, Yang M, Varon SF, Lee J, Kosinski M.
-
A qualitative study on feasibility of a web-based Women's Health Portal and Information System
Patient. 2011; 4(1):67-8
2011Yang M, Kosinski M, Boulanger R
-
Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors
Arthritis Res Ther. 2011 Feb 16; 13(1):R25
2011Rendas-Baum R, Wallenstein GV, Koncz T, Kosinski M, Yang M, Bradley J, Zwillich SH.
-
Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine
Cephalalgia. 2011 Feb; 31(3):357-67
2011Yang M, Rendas-Baum R, Varon SF, Kosinski M.
-
Measuring the health status burden in hemodialysis patients using the SF-36® health survey
Qual Life Res. 2011 Apr; 20(3):383-9
2011Yarlas AS, White MK, Yang M, Saris-Baglama RN, Bech PG, Christensen T
-
A novel approach to estimate the minimally important difference for the Fatigue Impact Scale in multiple sclerosis patients
Qual Life Res. 2010 Nov; 19(9):1349-58
2010Rendas-Baum R, Yang M, Cattelin F, Wallenstein GV, Fisk JD.
-
Interpreting Premenstrual Symptoms Impact Survey scores using outcomes in health-related quality of life and sexual drive impact
J Reprod Med. 2010 Jan-Feb; 55(1-2):41-8
2010Yang M, Gricar JA, Maruish ME, Hagan MA, Kornstein SG, Wallenstein GV
-
Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder
Appl Health Econ Health Policy. 2010; 8(2):129-40
2010Rendas-Baum R, Yang M, Gricar J, Wallenstein GV.
-
Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference
Curr Med Res Opin. 2009 Oct; 25(10): 2487-94
2009Yang M, Morin CM, Schaefer K, Wallenstein GV.
-
Comparability of the Asthma Control Test telephone interview administration format with self-administered mail-out mail-back format
Curr Med Res Opin. 2009 Mar; 25(3):717-27
2009Kosinski M, Kite A, Yang M, Rosenzweig JC, Williams A
-
Antipsychotic medication utilization trends among Texas veterans: 1997-2002
Ann Pharmacother. 2008 Sep; 42(9):1229-38
2008Yang M, Barner JC, Lawson KA, Rascati KL, Wilson JP, Crismon ML, Worchel J, Mascarenas CA.
-
Burden of premenstrual dysphoric disorder on health-related quality of life
J Womens Health (Larchmt). 2008 Jan-Feb; 17(1):113-21
2008Yang M, Wallenstein G, Hagan M, Guo A, Chang J, Kornstein S
-
An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension
J Clin Hypertens (Greenwich). 2008 Jun; 10(6):436-42
2008Williams SA, Michelson EL, Cain VA, Yang M, Nesbitt SD, Egan BM, Julius S; TROPHY Study Investigators
-
Factors related to antipsychotic oversupply among Central Texas Veterans
Clin Ther. 2007 Jun; 29(6):1214-25
2007Yang M, Barner JC, Worchel J.
-
Mapping MOS Sleep Scale scores to SF-6D utility index
Curr Med Res Opin. 2007 Sep; 23(9):2269-82
2007Yang M, Dubois D, Kosinski M, Sun X, Gajria K.
-
Frequency of new-onset diabetes mellitus and use of antipsychotic drugs among Central Texas veterans
Pharmacotherapy. 2004 Nov; 24(11):1529-38
2004Barner JC, Worchel J, Yang M.
News
-
January 09, 2019
-
June 19, 2018
-
April 16, 2018
-
October 25, 2017